My da|ra Login

Detailed view

metadata language: English

Perception and Memory Experiments Using Drug Names [2010, Canada]

Version
v0
Resource Type
Dataset : experimental data, text, survey data
Creator
  • Lambert, Bruce L. (BLL Consulting, Inc.)
  • Jelincic, Valentina (Institute for Safe Medication Practices Canada)
  • U, David (Institute for Safe Medication Practices Canada)
Other Title
  • Archival Version (Subtitle)
Publication Date
2013-04-03
Language
English
Free Keywords
brand names; cognition; cognitive processes; drug dispensing; drug education; drug industry; drug names; medications; prescription drugs
Description
  • Abstract

    Drug names that look and sound alike are a leading cause of medication errors (e.g., diazepam and diltiazem, hydroxyzine and hydralazine, Paxil and Taxol, fomepizole and omeprazole, Foradil and Toradol). Observational studies of dispensing in outpatient pharmacies suggest that the rate of wrong drug errors -- the type most likely to be the result of name confusion -- is roughly 0.13 percent. With 3.9 billion prescriptions dispensed in 2009, that translates to 5 million wrong drug errors per year in the United States. The purpose of this overall project was to develop, demonstrate, and disseminate a standard protocol for pre-approval testing of drug names, including a standard battery of psycholinguistic tests and data analytic methods, all with comparison to control names and to refine and demonstrate analytic methods by conducting a series of visual perception, auditory perception, and short term memory experiments using drug names as stimuli. The achievement of this aim will provide both regulators and pharmaceutical manufacturers with a scientifically validated, step-by-step method for testing new drug names for confusability. The data for this collection come from four experiments. In each experiment, participants are tested on their ability to correctly identify drug names under four conditions (see study design). Variables include participant reaction time to identify drug names and the percent participants correctly or incorrectly identified drug names. Study participants include medical doctors, nurse practitioners, pharmacists, and pharmacy technicians. Other variables include participant gender, education degree held, primary language spoken, and employment location.
  • Abstract

    The purpose of the present study was to refine and demonstrate analytic methods by conducting a series of visual perception, audutory perception, and short term memory experiments using drug names as stimuli.
  • Abstract

    There were four experiments in this study. For experiment one, Progressive Demasking Experiment (Part 1), the principal investigators used a cross-sectional, observational design to study clinicians' ability to correctly identify drug names presented visually on a laptop computer screen. The task that subjects engaged in is known as progressive demasking because it involves identifying a visual stimulus as it is progressively revealed from behind an obscuring mask of numbers. For experiment two, Visual Perception ("Pick from Pair") Experiment (Part 2), the principal investigators used a cross-sectional, observational design to study participants' ability to correctly select a target drug name from a pair of similar drug names after a brief visual presentation of the target on a computer monitor. For experiment three, Auditory Perception Experiment (Part 3), the principal investigators used a cross-sectional, observational design to study clinicians' ability to correctly identify a spoken drug name played back over headphones against a background of multi-speaker babble. This task is known as auditory perceptual identification. For experiment four, Recognition Memory Experiment (Part 4), the principal investigators used a cross-sectional, observational design to study clinicians' ability to correctly remember a drug name after it is briefly displayed on a computer screen. This task is known as recognition memory.
  • Methods

    ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection: Created variable labels and/or value labels.; Checked for undocumented or out-of-range codes..
  • Table of Contents

    Datasets:

    • DS0: Study-Level Files
    • DS1: Progressive Demasking Experiment Data
    • DS2: Visual Perception ("Pick from Pair") Experiment Data
    • DS3: Auditory Perception Experiment Data
    • DS4: Recognition Memory Experiment Data
Temporal Coverage
  • 2012-03-28 / 2012-03-29
    Time period: 2012-03-28--2012-03-29
  • 2012-07-05 / 2012-07-06
    Time period: 2012-07-05--2012-07-06
  • 2012-03-28 / 2012-03-29
    Collection date: 2012-03-28--2012-03-29
  • 2012-07-05 / 2012-07-06
    Collection date: 2012-07-05--2012-07-06
Geographic Coverage
  • Canada
  • Global
  • Ontario
Sampled Universe
Hospital-based clinicians (physicians, pharmacists, nurses) in Ontario, Canada.
Sampling
Convenience sample of clinicians working in a Canadian hospital.
Collection Mode
  • cognitive assessment test, on-site questionnaire

Note
2013-04-30 Updated list of principal investigators.
Availability
Delivery
This version of the study is no longer available on the web. If you need to acquire this version of the data, you have to contact ICPSR User Support (help@icpsr.umich.edu).
Alternative Identifiers
  • 34122 (Type: ICPSR Study Number)
Relations
  • Is previous version of
    DOI: 10.3886/ICPSR34122.v1

Update Metadata: 2015-08-05 | Issue Number: 6 | Registration Date: 2015-06-16

Lambert, Bruce L.; Jelincic, Valentina; U, David (2013): Perception and Memory Experiments Using Drug Names [2010, Canada]. Archival Version. Version: v0. ICPSR - Interuniversity Consortium for Political and Social Research. Dataset. https://doi.org/10.3886/ICPSR34122